Showing 9,041 - 9,060 results of 18,496 for search 'significantly ((((((a decrease) OR (largest decrease))) OR (greater decrease))) OR (mean decrease))', query time: 0.64s Refine Results
  1. 9041

    Individual data. by JoEllen M. Sefton (16880253)

    Published 2025
    “…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”
  2. 9042

    Descriptive statistics. by JoEllen M. Sefton (16880253)

    Published 2025
    “…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”
  3. 9043

    Time matched metabolic cost. by JoEllen M. Sefton (16880253)

    Published 2025
    “…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”
  4. 9044

    Research design. by JoEllen M. Sefton (16880253)

    Published 2025
    “…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”
  5. 9045

    Time matched physiological strain. by JoEllen M. Sefton (16880253)

    Published 2025
    “…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”
  6. 9046

    Physiological strain. by JoEllen M. Sefton (16880253)

    Published 2025
    “…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”
  7. 9047

    Diagram of exercise intervention progression. by JoEllen M. Sefton (16880253)

    Published 2025
    “…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”
  8. 9048

    Perceived exertion. by JoEllen M. Sefton (16880253)

    Published 2025
    “…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”
  9. 9049

    Metabolic cost. by JoEllen M. Sefton (16880253)

    Published 2025
    “…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”
  10. 9050
  11. 9051

    Average kidney and heart weight of rats. by Diana Bylan (20421873)

    Published 2024
    “…Dose-dependent experiments showed that COE (1 and 2μg/ml) induced a significant increase of phospho-(S473)-AKT along with a decrease in phospho (T180 + Y182) P38 levels.…”
  12. 9052

    Study selection flow diagram. by Laurence Weinberg (2960238)

    Published 2025
    “…</p><p>Conclusions</p><p>Although age alone should not preclude nonagenarians from undergoing cardiac surgery, the procedure is associated with a significantly elevated risk of morbidity and a relatively high mortality rate. …”
  13. 9053

    Inclusion and exclusion criteria. by Laurence Weinberg (2960238)

    Published 2025
    “…</p><p>Conclusions</p><p>Although age alone should not preclude nonagenarians from undergoing cardiac surgery, the procedure is associated with a significantly elevated risk of morbidity and a relatively high mortality rate. …”
  14. 9054

    Key characteristics of the included publications. by Laurence Weinberg (2960238)

    Published 2025
    “…</p><p>Conclusions</p><p>Although age alone should not preclude nonagenarians from undergoing cardiac surgery, the procedure is associated with a significantly elevated risk of morbidity and a relatively high mortality rate. …”
  15. 9055
  16. 9056

    Data Sheet 1_Assessing the efficacy and safety of pentoxifylline in preventing chemotherapy-induced peripheral neuropathy and mucositis in breast cancer patients.pdf by Samar A. Dewidar (22425457)

    Published 2025
    “…</p>Conclusion<p>The co-administration of PTX with AC/T chemotherapy in breast cancer patients significantly decreases the incidence and postpones the onset of grade 2 or higher peripheral neuropathy and the incidence of mucositis without causing additional risks for the patients.…”
  17. 9057
  18. 9058
  19. 9059
  20. 9060